Contribution of calpain to cellular damage in human retinal pigment epithelial cells cultured with zinc chelator

Current Eye Research

Volumn 32, Issue 6, 2007, Pages 565-573

  Tamada, Yoshiyuki ^a   Walkup, Ryan D ^a   Shearer, Thomas R ^b   Azuma, Mitsuyoshi ^a,b  

^a Senju Laboratory of Ocular Sciences   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

spectrin; Calpain; Retinal pigment epithelial cells; SJA6017; Zinc chelator

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CALPAIN; CALPASTATIN; CASEIN; CHELATING AGENT; FODRIN; LACTATE DEHYDROGENASE; MESSENGER RNA; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; SJA 6017; UNCLASSIFIED DRUG; ZINC;

ADDITION REACTION; ADULT; AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL STRUCTURE; CHOROID; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NICK END LABELING; PHASE CONTRAST MICROSCOPE; PIGMENT CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUALITATIVE ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; ZINC DEFICIENCY; ZYMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CALCIUM; CALPAIN; CASPASE 3; CELLS, CULTURED; CHELATING AGENTS; DIPEPTIDES; ETHYLENEDIAMINES; HUMANS; IN SITU NICK-END LABELING; L-LACTATE DEHYDROGENASE; MICROSCOPY, PHASE-CONTRAST; MIDDLE AGED; OLIGOPEPTIDES; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTRIN; ZINC;

EID: 34447115118     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701359633     Document Type: Article

References (38)

1. Zinn KM, Benjamin-Henkind JV. Anatomy of the human retinal pigment epithelium. In: Zinn KM, Marmor MF, eds. The Retinal Pigment Epithelium. Cambridge: Harvard University Press; 1979:3-31.
2. Hogan MJ, Alvarado JA, Weddell JE. The retinal pigment epithelium. In: Hogan MJ, Alvarado JA, Weddell JE, eds. Histology of the Human Eye. Philadelphia: WB Saunders; 1971:405-423.
3. Bosch E, Horwitz J, Bok D. Phagocytosis of outer segments by retinal pigment epithelium: phagosome-lysosome interaction. J Histochem Cytochem. 1993;41:253-263.
4. Bok D, Hall MO. The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J Cell Biol. 1971;49:664-682.
5. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32:375-413.
6. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450-1460.
7. Hogan MJ. Role of the retinal pigment epithelium in macular diseas. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:64-80.
8. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106:192-198.
9. Tate DJ, Miceli MV, Newsome DA, Alcock NW, Oliver PD. Influence of zinc on selected cellular functions of cultured human retinal pigment epithelium. Curr Eye Res. 1995;14:897-903.
10. Klein R. Epidemiology. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St Louis: Mosby; 1999:31-55.
11. van der Schaft TL, de Bruijn WC, Mooy CM, Ketelaars DA, de Jong PT. Element analysis of the early stages of age-related macular degeneration. Arch Ophthalmol. 1992;110:389-394.
12. Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.
13. USA Brown NA, Bron AJ, Harding JJ, Dewar HM. Nutrition supplements and the eye. Eye. 1998;12:127-133.
14. Tate DJ Jr, Miceli MV, Newsome DA. Zinc protects against oxidative damage in cultured human retinal pigment epithelial cells. Free Radic Biol Med. 1999;26:704-713.
15. Hyun HJ, Sohn JH, Ha DW, Ahn YH, Koh JK, Yoon YH. Depletion of intracellular zinc and copper with TPEN results in apoptosis of cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:460-465.
16. Squier M, Miller AC, Malkinson AM, Cohe JJ. Calpain activation in apoptosis. J Cell Physiol. 1994;159:229-237.
17. Martin SJ, O'Brien GA, Nishioka WK, et al. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem. 1995;270:6425-6428.
18. McGinnis KM, Whitton MM, Gnegy ME, Wang KKW. Calcium/calmodulin-dependent protein kinase IV is cleaved by caspace-3 and calpain in SH-SY5Y human neuroblastroma cells undergoing apoptosis. J Biol Chem. 1998;3:19993-20000.
19. Tamada Y, Fukiage C, Daibo S, Yoshida Y, Azuma M, Shearer TR. Involvement of calpain in hypoxia-induced damage in rat retina in vitro. Comp Biochem Physiol. 2002;131:221-225.
20. Tamada Y, Nakajima E, Nakajima T, Shearer TR, Azuma M. Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia. Brain Res. 2005;1050:148-155.
21. Sakamoto Y, Nakajima T, Fukiage C, et al. Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina. Curr Eye Res. 2000;21:571-580.
22. Azuma M, Sakamoto-Mizutani K, Nakajima T, Kanaami-Daibo S, Tamada Y, Shearer TR. Involvement of calpain isoforms in retinal degeneration in WBN/Kob rats. Comp Med. 2004;54:533-542.
23. Sharma AK, Rohrer B. Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem. 2004;279:35564-35572.
24. Pffefer BA. Improved methodology for cell culture of human and monkey retinal pigment epithelium. In: Osborne NN, Chader G, eds. Progress in retinal research. vol 10, Oxford: Pergamon Press; 1990:251-291.
25. Ando A, Ueda M, Uyama M, Masu Y, Ito S. Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Br J Ophthalmol. 2000;84:1306-1311.
26. Inoue J, Nakamura M, Cui YS, Sakai Y, et al. Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L- leucinal (SJA6017) as a potent calpain inhibitor. J Med Chem. 2003;46:868-871.
27. Frankel A, Man S, Elliott P, Adams J, Kerbel RS. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res. 2000;6:3719-3728.
28. Verdaguer E, Alvira D, Jimenez A, Rimbau V, Camins A, Pallas M. Inhibition of the cdk5/MEF2 pathway is involved in the antiapoptotic properties of calpain inhibitors in cerebellar neurons. Br J Pharmacol. 2005;145:1103-1111.
29. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 1987;20:83-90.
30. David LL, Varnum MD, Lampi KJ, Shearer TR. Calpain II in human lens. Invest Ophthalmol Vis Sci. 1989;30:269-275.
31. Racer KJ, Posner A, Wang KKW. Casein zymography: a method to study mu-calpain, m-calpain, and their inhibitory agents. Arch Biochem Biophys. 1995;319:211-216.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
33. Schoenwaelder SM, Kulkarni S, Salem HH, et al. Distinct substrate specificities and functional roles for the 78- and 76-kDa forms of mu-calpain in human platelets. J Biol Chem. 1997;272:24876-24884.
34. Azuma M, Fukiage C, David LL, Shearer TR. Activation of calpain in lens: a review and proposed mechanism. Exp Eye Res. 1997;64:529-538.
35. Nakamura Y, Fukiage C, Ma H, Shih M, Azuma M, Shearer TR. Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor. Exp Eye Res. 1999;69:155-162.
36. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83:731-801.
37. Wang KKW, Nath R, Posner A, et al. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci USA. 1996;93:6687-6692.
38. Fukiage C, Azuma M, Nakamura Y, Tamada Y, Nakamura M, Shearer TR. SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses. Biochim Biophys Acta. 1997;1361:304-312.